Clearline Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,394
| Closed | -$854K | – | 104 |
|
|
2023
Q3 | $854K | Sell |
32,394
-230,526
| -88% | -$6.08M | 0.07% | 105 |
|
|
2023
Q2 | $4.52M | Sell |
262,920
-2,120
| -0.8% | -$36.5K | 0.26% | 51 |
|
|
2023
Q1 | $4.39M | Sell |
265,040
-27,200
| -9% | -$451K | 0.66% | 45 |
|
|
2022
Q4 | $2.23M | Buy |
292,240
+11,338
| +4% | +$86.4K | 0.4% | 62 |
|
|
2022
Q3 | $2.79M | Sell |
280,902
-149,674
| -35% | -$1.49M | 0.33% | 63 |
|
|
2022
Q2 | $3.91M | Buy |
430,576
+74,512
| +21% | +$677K | 0.51% | 49 |
|
|
2022
Q1 | $3.61M | Buy |
+356,064
| New | +$3.61M | 0.42% | 55 |
|